These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1011187)

  • 1. [Applications of the normal standard dose in clinical practice].
    Abbatucci JS
    J Radiol Electrol Med Nucl; 1976 Nov; 57(11):817-25. PubMed ID: 1011187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development and utilization of the Nominal Standard Dose for the tolerance dosage to healthy tissue in radiotherapy].
    Gabriel-Jürgens P; Gremmel H; Wendhausen H
    Strahlentherapie; 1976 Feb; 151(2):99-112. PubMed ID: 1258089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some aspects of the chronological dose distribution in the radiobiology and radiotherapy.
    Ulmer W
    Strahlenther Onkol; 1986 Jun; 162(6):374-86. PubMed ID: 3738738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of the time factor in clinical radiotherapy. I. The historical background of the recovery exponents.
    Fletcher GH; Barkley HT
    J Radiol Electrol Med Nucl; 1974; 55(6-7):443-50. PubMed ID: 4419735
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimalization of radiotherapy of skin epitheliomas: role of the NSD].
    Abbatucci JS
    J Radiol Electrol Med Nucl; 1977 Nov; 58(11):748-50. PubMed ID: 592256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present status of the time factor in clinical radiotherapy. II. The nominal standard dose formula.
    Fletcher GH; Barkley HT; Shukovsky LJ
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):748-51. PubMed ID: 4452951
    [No Abstract]   [Full Text] [Related]  

  • 8. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose of tissue tolerance, dose of tumour sterilisation in continuous and discontinuous irradiation (author's transl)].
    Swyngedauw J
    J Radiol Electrol Med Nucl; 1975 May; 56(5):369-81. PubMed ID: 1177183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational dosimetry tool for the study of tumor doses and skin toxicities in BNCT.
    Gossio S; Carando DG; González SJ
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S145-8. PubMed ID: 19386508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors influencing the response of normal tissue to radiation].
    Masuda K; Jingu K; Hayabuchi N; Miyoshi M; Hirata H
    Gan No Rinsho; 1987 Oct; 33(13):1551-9. PubMed ID: 3694794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: The effects of varied numbers of dose fractions and overall treatment time on the radiation response of normal human skin.
    Young CM; Brennan D; Durrant K; Hopewell JW; Wiernik G
    Br J Radiol; 1976 Jun; 49(582):558. PubMed ID: 1276634
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the dose dependency of various x-ray induced late symptoms of the skin].
    Klostermann GF
    Z Haut Geschlechtskr; 1966 Aug; 41(4):132-40. PubMed ID: 5992175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reirradiation of normal tissues: preclinical radiobiological data].
    Bourgier C; Vozenin MC; Deutsch E
    Cancer Radiother; 2010 Oct; 14(6-7):412-5. PubMed ID: 20727804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Time factors in human skin desquamations (author's transl)].
    Dutreix J; Wambersie A
    J Radiol Electrol Med Nucl; 1976 Nov; 57(11):813-6. PubMed ID: 1011186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of low dose hyper-radiosensitivity in normal human skin.
    Harney J; Shah N; Short S; Daley F; Groom N; Wilson GD; Joiner MC; Saunders MI
    Radiother Oncol; 2004 Mar; 70(3):319-29. PubMed ID: 15064019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficient parameters of grid diaphragms for the radiation therapy of malignant tumors].
    Klepper LIa
    Med Radiol (Mosk); 1989 Jul; 34(7):63-7. PubMed ID: 2761375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Approximate methods for calculation of the likelihood of radiation complications. The generalized PKLQ method (GPKLQM)].
    Klepper LIa
    Med Tekh; 2002; (5):27-32. PubMed ID: 12512280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [X-ray treatment of skin neoplasms by means of the fractionation method].
    Kik A
    Przegl Dermatol; 1972; 59(4):571-5. PubMed ID: 4560871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.